SCHEMBL2438488

SCHEMBL2438488

Cc1cccc2cc(Cc3cnc(N)nc3N)c(-c3ccccc3Cl)nc12

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 12/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1883710 0.84 DHFR (0.47)
SCHEMBL1313156 0.81 PIK3CD (0.63) PIK3CD
SCHEMBL1312945 0.79 PIK3CD (0.64) PIK3CD
SCHEMBL2434233 0.79 PIK3CD (0.50) PIK3CD
SCHEMBL4442988 0.78 PIK3CD (0.63) PIK3CD
SCHEMBL1597713 0.78 PIK3CD (0.65) PIK3CD
SCHEMBL6745119 0.77 PIK3CD (0.62) PIK3CD
SCHEMBL1598041 0.77 PIK3CD (0.64) PIK3CD
SCHEMBL1886097 0.77 PIK3CD (0.64) PIK3CD
SCHEMBL1313191 0.76 PIK3CD (0.58) PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2365810-A2 PHOSPHATIDYLINOSITOL-3-KINASE P110 DELTA-TARGETED DRUGS IN THE TREATMENT OF CNS DISORDERS The U.S.A. As Represented By The Secretary, Department Of Health And Human Services (US) 2011-09-21 EP disclosed